Hypoglycaemia risk with insulin degludec compared with insulin glargine in type 2 and type 1 diabetes: a pre-planned meta-analysis of phase 3 trials

AIM: Hypoglycaemia and the fear of hypoglycaemia are barriers to achieving normoglycaemia with insulin. Insulin degludec (IDeg) has an ultra-long and stable glucose-lowering effect, with low day-to-day variability. This pre-planned meta-analysis aimed to demonstrate the superiority of IDeg over insu...

Descripción completa

Detalles Bibliográficos
Autores principales: Ratner, R E, Gough, S C L, Mathieu, C, Del Prato, S, Bode, B, Mersebach, H, Endahl, L, Zinman, B
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2013
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3752969/
https://www.ncbi.nlm.nih.gov/pubmed/23130654
http://dx.doi.org/10.1111/dom.12032

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3752969/
https://www.ncbi.nlm.nih.gov/pubmed/23130654
http://dx.doi.org/10.1111/dom.12032

Ejemplares similares